JP2001272406A - Container for high-sensitivity analysis - Google Patents
Container for high-sensitivity analysisInfo
- Publication number
- JP2001272406A JP2001272406A JP2000085356A JP2000085356A JP2001272406A JP 2001272406 A JP2001272406 A JP 2001272406A JP 2000085356 A JP2000085356 A JP 2000085356A JP 2000085356 A JP2000085356 A JP 2000085356A JP 2001272406 A JP2001272406 A JP 2001272406A
- Authority
- JP
- Japan
- Prior art keywords
- functional group
- container
- well
- solution
- adsorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、抗原抗体反応を利
用して抗体又は抗原を検出する免疫分析の内、抗体又は
抗原等の分子を容器に固相化して測定を行う固相法に用
いる容器の材質及び表面処理に関するものである。The present invention relates to an immunoassay for detecting an antibody or an antigen utilizing an antigen-antibody reaction, which is used in a solid phase method in which a molecule such as an antibody or an antigen is immobilized on a container for measurement. It relates to the material and surface treatment of the container.
【0002】[0002]
【従来の技術】従来の固相法による免疫測定において
は、ポリスチレン等のプラスチック基材に非特異的吸着
を利用して抗体又は抗原等の分子を固相化し、固相化し
た分子に対して免疫反応を利用してサンプル溶液(検
体)中の目的の分子を捕捉させ、最終的にラジオアイソ
トープ、酵素、蛍光物質等で標識した分子を目的の分子
に特異的に捕捉させて定量する方法が一般的に行われて
いる。しかし、そのように非特異的吸着を利用した方法
では固相化以降に加える分子も基材に非特異的に吸着し
てしまうため、本来特異的な抗原抗体反応で捕捉された
分子の量だけをシグナルとしてとらえるべきところが、
非特異的吸着により基材に残留した夾雑物の量がノイズ
として出てきてしまう。2. Description of the Related Art In a conventional immunoassay using a solid phase method, a molecule such as an antibody or an antigen is immobilized on a plastic substrate such as polystyrene by using nonspecific adsorption, and the immobilized molecule is immobilized on the immobilized molecule. A method of capturing target molecules in a sample solution (analyte) using an immune reaction, and finally capturing and quantifying molecules labeled with radioisotopes, enzymes, fluorescent substances, etc. Generally done. However, in such a method using non-specific adsorption, molecules to be added after immobilization are also non-specifically adsorbed on the substrate, so that only the amount of molecules originally captured by the specific antigen-antibody reaction is used. Should be taken as a signal,
The amount of contaminants remaining on the substrate due to non-specific adsorption comes out as noise.
【0003】そこで、一般的にはブロッキングといっ
た、夾雑物の吸着を防止する作業が必要である。ブロッ
キングとは、固相化後の表面に、吸着し易く系に影響を
及ぼさない蛋白を接触させて固相化されていない部分を
マスキングする作業である。ところが、例え基材表面を
ブロッキング蛋白で完全に覆ったとしても、一般的に蛋
白質は吸着によりその高次構造が崩れる(変成)ことで
二次的な吸着を誘引する為、ブロッキング蛋白上への非
特異吸着が発生してしまい、充分な効果は得られない場
合が多い。更に、ブロッキング蛋白は生体由来物質であ
るため、品質の安定性の面でも問題があり、測定日が異
なると再現性が得られないケースも多い。また、ポリビ
ニルピロリドン等の親水性ポリマーを使用した人工的な
ブロッキング剤も市販されているが、それら親水性ポリ
マーは疎水性の容器基材との相互作用が弱く、非特異的
な吸着で基材表面に導入することは非常に困難で、洗浄
により容易に剥離するため充分な効果を得る事は難しか
った。[0003] Therefore, it is generally necessary to perform an operation for preventing adsorption of foreign substances such as blocking. The blocking is an operation of contacting a protein that is easily adsorbed and does not affect the system to the surface after immobilization, thereby masking a portion that is not immobilized. However, even if the surface of the base material is completely covered with the blocking protein, the protein generally loses its higher-order structure due to adsorption (denaturation) and induces secondary adsorption. In many cases, nonspecific adsorption occurs, and a sufficient effect cannot be obtained. Furthermore, since the blocking protein is a biological substance, there is a problem in quality stability, and reproducibility cannot be obtained in many cases on different measurement dates. Artificial blocking agents using hydrophilic polymers such as polyvinylpyrrolidone are also commercially available, but these hydrophilic polymers have weak interaction with the hydrophobic container base material, and the non-specific adsorption causes the base material to become non-specific. It is very difficult to introduce it on the surface, and it is difficult to obtain a sufficient effect because it is easily peeled off by washing.
【0004】次に、抗体又は抗原等の分子を固相化させ
る工程について考えてみると、現状の非特異的吸着を利
用した固相化においては飽和吸着濃度以上の濃度の固相
化分子の溶液を接触させた後に洗浄する方法が一般的で
あるが、固相化分子に多層吸着が存在した場合、後から
反応させる検体、標識抗体等の分子が比較的吸着力の弱
い多層部分と反応すると、後の洗浄で洗い流されてしま
い、検体中の目的分子の量に応じたシグナルが得られな
い、又はばらつきが大きくなるといった原因になる。つ
まり、現状では固相法での免疫分析において、ノイズの
発生、ばらつきの原因は殆どが容器基材への非特異的吸
着に起因しており、非特異的吸着は排除すべきであるに
も係わらず、容器基材への固相化には非特異的吸着を利
用せざるを得ないといった矛盾が解決できていない状況
であった。[0004] Next, considering the step of immobilizing a molecule such as an antibody or an antigen, the immobilization utilizing the non-specific adsorption of the present state requires the immobilization of an immobilized molecule having a concentration higher than the saturation adsorption concentration. Generally, washing is performed after contacting the solution.However, when multi-layer adsorption is present on immobilized molecules, molecules to be reacted later, such as analytes and labeled antibodies, react with the multi-layer part with relatively weak adsorption power. Then, it is washed away in the subsequent washing, and a signal corresponding to the amount of the target molecule in the sample cannot be obtained, or the variation becomes large. In other words, at present, in the immunoassay using the solid-phase method, most of the causes of noise and variations are caused by non-specific adsorption to the container substrate, and non-specific adsorption should be excluded. Regardless, the contradiction that non-specific adsorption must be used for immobilization on the container base material has not been solved.
【0005】[0005]
【発明が解決しようとする課題】本発明は、このような
従来の問題点を解決すべく鋭意検討の結果なされたもの
で、安定した固相化が可能で、ブロッキング工程の不要
な高感度免疫測定用容器の提供を目的とするものであ
る。DISCLOSURE OF THE INVENTION The present invention has been made as a result of intensive studies in order to solve such conventional problems, and it is possible to stably immobilize a solid phase and eliminate the need for a blocking step. It is intended to provide a container for measurement.
【0006】[0006]
【課題を解決するための手段】即ち本発明の第一の発明
は、容器の少なくとも試薬溶液と接触する基材部分に官
能基を有する親水性の高分子がグラフト化されている事
を特徴とする高感度免疫分析容器であり、さらに第二の
発明は容器の少なくとも試薬溶液と接触する基材部分に
官能基及び親水性の高分子がグラフト化されている事を
特徴とする高感度免疫分析容器である。That is, a first aspect of the present invention is characterized in that a hydrophilic polymer having a functional group is grafted on at least a substrate portion of a container which comes into contact with a reagent solution. And a functional group and a hydrophilic polymer are grafted on at least a substrate portion of the container in contact with the reagent solution. Container.
【0007】[0007]
【発明の実施の形態】本発明の特徴としては、容器基材
表面に親水性のポリマーと官能基を導入する事で、非特
異的吸着を低減し、目的の分子のみを共有結合によって
確実に固相化させることを可能にしている点である。親
水性ポリマーは、ポリメタクリル酸、メタクリル酸−ア
ルキルメタクリレート共重合体、ポリヒドロキシアルキ
ルメタクリレート、ヒドロキシアルキルメタクリレート
−アルキルメタクリレート共重合体、ポリオキシアルキ
レン基含有メタクリレート重合体又はこれを含む共重合
体、エチレンビニルアルコール共重合体、リン脂質・高
分子複合体、ポリエチレンオキシド、ポリビニルピロリ
ドン等及び、これらの分子の少なくとも1種類を側鎖に
もつポリマーが好ましい。又、官能基としては、固相化
を行う分子との結合が可能なものであれば特に限定する
ものではないが、アミノ基、カルボキシル基、メルカプ
ト基等が挙げられる。DESCRIPTION OF THE PREFERRED EMBODIMENTS The feature of the present invention is that a non-specific adsorption is reduced by introducing a hydrophilic polymer and a functional group on the surface of a container substrate, and only a target molecule is surely covalently bonded. This is the point that the solid phase can be formed. The hydrophilic polymer is polymethacrylic acid, methacrylic acid-alkyl methacrylate copolymer, polyhydroxyalkyl methacrylate, hydroxyalkyl methacrylate-alkyl methacrylate copolymer, polyoxyalkylene group-containing methacrylate polymer or a copolymer containing the same, ethylene Vinyl alcohol copolymers, phospholipid / polymer complexes, polyethylene oxide, polyvinylpyrrolidone, and the like, and polymers having at least one of these molecules in the side chain are preferable. The functional group is not particularly limited as long as it can bind to a molecule to be solid-phased, and examples thereof include an amino group, a carboxyl group, and a mercapto group.
【0008】官能基を有する親水性ポリマーをグラフト
化させる方法としては、成形した容器基材の表面に重
合開始点を生成し、そこに結果的に官能基と親水性基を
有するようなモノマーを重合、生長させる方法、または
成形した容器基材の表面に官能基を生成させ、その官
能基に対して官能基を有する親水性ポリマーを結合させ
る方法、または容器基材の原料に、官能基を有する親
水性ポリマーのグラフト共重合体を添加し成形する方法
等が考えられる。上記の中で最も容易に導入が可能な方
法はの方法であり、一般的にはポリスチレンで成形さ
れている容器基材を酸素プラズマ処理によりカルボキシ
ル基を生成またはアンモニアプラズマによりアミノ基を
生成させた表面に一方にカルボキシル基又はアミノ基を
持つ二官能性の親水性ポリマーをカルボジイミド等を用
いてカップリングさせる事で本発明を達成することが出
来る。As a method for grafting a hydrophilic polymer having a functional group, a polymerization starting point is formed on the surface of a molded container substrate, and a monomer having a functional group and a hydrophilic group is consequently added thereto. Polymerization, a method of growing, or a method of forming a functional group on the surface of a molded container base material, and bonding a hydrophilic polymer having a functional group to the functional group, or a method of adding a functional group to the raw material of the container base material A method of adding a graft copolymer of a hydrophilic polymer having the compound and molding the mixture can be considered. Among the above methods, the method which can be introduced most easily is the method described below. In general, a carboxyl group is generated by oxygen plasma treatment on a container base material formed of polystyrene or an amino group is generated by ammonia plasma. The present invention can be achieved by coupling a bifunctional hydrophilic polymer having a carboxyl group or an amino group on one surface with carbodiimide or the like.
【0009】尚、本発明に於いては、官能基と親水性ポ
リマーが表面に共存していれば良く、上記のように官能
基を有する親水性ポリマーを使用せず、官能基と親水性
ポリマーを各々表面に導入しても良く、その場合でも基
本的に上記〜の方法を用いる事が出来る。上記によ
り表面に導入された官能基と親水性ポリマーの模式図の
例を図面に示す。尚、本発明はこれらに限定されるもの
ではない。In the present invention, it is sufficient that the functional group and the hydrophilic polymer coexist on the surface, and the functional group and the hydrophilic polymer are not used as described above. May be introduced into each surface, and even in that case, the above-mentioned methods (1) to (4) can be basically used. An example of a schematic diagram of the functional group and the hydrophilic polymer introduced on the surface as described above is shown in the drawing. Note that the present invention is not limited to these.
【0010】容器基材への非特異的吸着を低減するため
に親水性ポリマーを導入した理由は、水性溶媒中での非
特異吸着が疎水結合に大きく依存しており、表面の親水
化は幅広い種類の分子の非特異吸着を低減することが出
来るためである。非特異吸着を全く無くす事が出来れ
ば、理論上ノイズはゼロとなり最も理想的であるが、実
際にはノイズの大きさが得られるシグナルに比べて充分
小さければ問題は無く、必ずしも非特異吸着をゼロにす
る必要は無い。The reason for introducing a hydrophilic polymer in order to reduce non-specific adsorption to a container substrate is that non-specific adsorption in an aqueous solvent largely depends on hydrophobic bonds, and the surface hydrophilicity is wide. This is because non-specific adsorption of the kinds of molecules can be reduced. If non-specific adsorption can be eliminated at all, the noise is theoretically zero and the most ideal.However, in practice there is no problem if the noise is sufficiently smaller than the signal to be obtained. There is no need to make it zero.
【0011】つまり、固相化する分子の導入量、官能基
の数、官能基と固相化する分子の反応効率、また検体中
の測定すべき目的物の量に応じて親水性ポリマーの導入
量を変えても良い。一般的には表面の水との接触角が1
度以下になる様に親水性ポリマーを導入すれば、幅広い
分子に対して充分な非特異吸着制御性が得られる。ま
た、容器基材に導入する官能基の密度については、容器
基材の官能基と固相化分子との反応性にもよるが、通常
10pmol/cm2以上であることが好ましい。That is, the introduction of the hydrophilic polymer depends on the amount of the molecule to be immobilized, the number of functional groups, the reaction efficiency between the functional group and the molecule to be immobilized, and the amount of the target substance to be measured in the sample. The amount may be changed. Generally, the contact angle with water on the surface is 1
When a hydrophilic polymer is introduced so as to have a degree of lower than the degree, sufficient nonspecific adsorption controllability for a wide range of molecules can be obtained. In addition, the density of the functional group introduced into the container substrate depends on the reactivity between the functional group of the container substrate and the immobilized molecule.
It is preferably at least 10 pmol / cm 2 .
【0012】実際に本発明を用いて免疫分析を行う手順
は、先ず任意の固相化分子を容器基材表面の官能基と結
合させる。結合の方法としては、官能基の種類等によっ
ても異なるが、容器基材表面のカルボキシル基に対して
固相化分子のアミノ基を反応させる場合にはカルボジイ
ミド等の縮合剤を用いる、また容器基材のアミノ基に対
して固相化分子のアミノ基を反応させる場合にはグルタ
ルアルデヒドを用いれば良い。次に未反応の固相化分子
を洗浄し、必要に応じて未反応の官能基を不活化する。
以降は通常の免疫分析工程を続けて行けば良いが、ブロ
ッキング工程は不要である。以下、実施例によって本発
明を更に具体的に説明するが、本発明はこれらの実施例
に限定されるものではない。In the procedure for actually performing an immunoassay using the present invention, first, an arbitrary solid-phased molecule is bonded to a functional group on the surface of a container substrate. The method of bonding varies depending on the type of the functional group and the like, but when the amino group of the immobilized molecule is reacted with the carboxyl group on the surface of the container base material, a condensing agent such as carbodiimide is used. When reacting the amino group of the solid-phased molecule with the amino group of the material, glutaraldehyde may be used. Next, the unreacted solid-phased molecules are washed, and if necessary, the unreacted functional groups are inactivated.
Thereafter, the normal immunoassay step may be continued, but the blocking step is not required. Hereinafter, the present invention will be described more specifically with reference to Examples, but the present invention is not limited to these Examples.
【0013】[0013]
【実施例】(実施例)ポリスチレン製96穴マルチウェ
ルプレート(住友ベークライト製 MS−8496F)
をγ線(50kGy)照射により基材表面に水酸基を生成さ
せた。ポリエチレングリコール(和光純薬製 平均分子
量400)の1.5%メタノール溶液を上記プレートに
200μl/wellで分注し、10分後に吸引、廃棄
した。次にγ−(2−アミノエチル)アミノプロピルト
リメトキシシラン(東レダウシリコーン製 SH−60
20)の3%メタノール溶液を200μl/wellで
分注し、プレートミキサーにて60秒攪拌した後に、室
温にて4時間静置した。静置後ウェルの溶液を捨て、プ
レートを5%エタノール水溶液にて洗浄、50℃の乾燥
機で3時間乾燥させた。以上の工程により表面にポリエ
チレングリコール鎖とアミノ基を導入したプレートを作
製し実施例とした。EXAMPLES (Example) Polystyrene 96-well multiwell plate (MS-8496F, manufactured by Sumitomo Bakelite)
Was irradiated with γ-rays (50 kGy) to form hydroxyl groups on the substrate surface. A 1.5% methanol solution of polyethylene glycol (manufactured by Wako Pure Chemical Industries, average molecular weight: 400) was dispensed into the above plate at 200 μl / well, and after 10 minutes, aspirated and discarded. Next, γ- (2-aminoethyl) aminopropyltrimethoxysilane (SH-60 manufactured by Toray Dow Silicone)
The 3% methanol solution of 20) was dispensed at 200 μl / well, stirred for 60 seconds with a plate mixer, and allowed to stand at room temperature for 4 hours. After standing, the well solution was discarded, and the plate was washed with a 5% aqueous ethanol solution and dried with a dryer at 50 ° C. for 3 hours. A plate having a polyethylene glycol chain and an amino group introduced into the surface was prepared through the above steps, and the plate was used as an example.
【0014】(比較例1)表面にアミノ基をもつポリス
チレン製96穴マルチウェルプレート(住友ベークライ
ト製 MS−8696F)を比較例1とした。 (比較例2)ポリスチレン製96穴マルチウェルプレー
ト(住友ベークライト製 MS−8496F)にポリ−
2−ヒドロキシエチルメタクリレート(シグマ製 P−
3932)の3%メタノール溶液を200μl/wel
lで分注し、風乾させる事で表面を親水化したプレート
を比較例2とした。 (比較例3)未処理のポリスチレン製96穴マルチウェ
ルプレート(住友ベークライト製MS−8496F)を
比較例3とした。Comparative Example 1 A 96-well multi-well plate made of polystyrene having an amino group on its surface (MS-8696F manufactured by Sumitomo Bakelite) was used as Comparative Example 1. (Comparative Example 2) Polystyrene was added to a 96-well multiwell plate made of polystyrene (MS-8496F, manufactured by Sumitomo Bakelite).
2-hydroxyethyl methacrylate (Sigma P-
3932) in 200 μl / well
The plate was dispensed in 1 l and air-dried to make the surface hydrophilic. Comparative Example 3 An untreated polystyrene 96-well multiwell plate (Sumitomo Bakelite MS-8496F) was used as Comparative Example 3.
【0015】上記実施例及び比較例1、2のプレートを
用いて、表面接触角の測定、蛋白吸着量の比較、カップ
リング剤処理後の蛋白固相化量の比較を行った。 1.表面接触角の測定 接触角計(協和界面化学製 CA S−150)を用い
て接触角を測定した。尚接測定は各プレートのウェルの
底面を切り出して行った。測定結果は第1表の通り。 2.蛋白吸着量の比較 蛋白吸着量は酵素標識抗体溶液を直接各プレートに接触
させ、洗浄後に残った量を基質液の発色量にて測定し
た。Using the plates of the above Examples and Comparative Examples 1 and 2, the surface contact angle was measured, the amount of adsorbed protein was compared, and the amount of immobilized protein after the treatment with the coupling agent was compared. 1. Measurement of surface contact angle The contact angle was measured using a contact angle meter (CAS-150, manufactured by Kyowa Interface Science). The contact measurement was performed by cutting out the bottom of the well of each plate. Table 1 shows the measurement results. 2. Comparison of Protein Adsorption Amount of protein adsorption was determined by directly contacting the enzyme-labeled antibody solution with each plate, and measuring the amount remaining after washing by the amount of color developed in the substrate solution.
【0016】アルカリフォスファターゼ標識ヒトIgG
(シグマ製 A3150)のリン酸緩衝液(pH7.
4)溶液(0.2μg/ml)を各プレートに200μ
l/ウェルで分注し、37℃で1時間静置し吸着させ
た。静置後ウェル内の溶液を捨て、0.05%Twee
n20を加えたリン酸緩衝液で3回洗浄した。洗浄後、
各ウェルにフェノールフタレイン1リン酸基質液を10
0μl/wellで分注し、室温で30分反応させた後
にリン酸水素2ナトリウム+EDTA水溶液を50μl
/wellで加えて反応を停止させた。プレートリーダ
ー(コロナ製 MTP−32)で550nmの吸光度を
測定した。測定結果は第1表の通り。Alkaline phosphatase-labeled human IgG
(Sigma A3150) phosphate buffer (pH 7.
4) Add 200 μl of solution (0.2 μg / ml) to each plate
1 / well and allowed to stand at 37 ° C. for 1 hour for adsorption. After standing, the solution in the well is discarded, and 0.05% Tween is added.
The plate was washed three times with a phosphate buffer containing n20. After washing
Add 10 phenolphthalein monophosphate substrate solutions to each well.
After dispensing at 0 μl / well and reacting at room temperature for 30 minutes, 50 μl of disodium hydrogen phosphate + EDTA aqueous solution was added.
The reaction was stopped by adding / well. The absorbance at 550 nm was measured with a plate reader (MTP-32 manufactured by Corona). Table 1 shows the measurement results.
【0017】3.カップリング剤処理の有無による蛋白
固相化量の比較 各プレートを予めグルタルアルデヒド(和光製 ab
t.20%電子顕微鏡用)の2%リン酸緩衝液溶液を1
00μl/ウェルで分注し室温20分静置後、純水洗浄
した後に上記2.蛋白吸着量の比較で用いた測定法で測
定した。測定結果は表1の通り。3. Comparison of the amount of immobilized protein with and without the coupling agent treatment Each plate was previously prepared using glutaraldehyde (Wako ab
t. 2% phosphate buffer solution (for 20% electron microscope)
After dispensing at 00 μl / well, allowing to stand at room temperature for 20 minutes, washing with pure water, It was measured by the measurement method used for comparison of the protein adsorption amount. Table 1 shows the measurement results.
【0018】[0018]
【表1】 [Table 1]
【0019】接触角が0度である実施例と比較例2では
蛋白の吸着量は低く、実施例ではカップリング剤処理を
行うことで固相化量が増加することが認められた。即
ち、実施例においては表面の親水性により蛋白質の物理
吸着が抑えられ、表面の官能基により共有結合で蛋白が
固相化されることが示された。次に、実施例及び比較例
3を用いて実際の免疫分析法(サンドイッチ法)によ
り、測定感度の比較を行った。実施例については、予め
グルタルアルデヒド(和光製 abt.20%電子顕微
鏡用)の2%リン酸緩衝液溶液を各プレートに200μ
l/wellで分注し、室温で20分静置後純水で洗浄
した。In the example and the comparative example 2 in which the contact angle was 0 degree, the amount of adsorbed protein was low, and in the example, it was recognized that the amount of solid phase increased by performing the coupling agent treatment. That is, in the examples, it was shown that the physical adsorption of the protein was suppressed by the hydrophilicity of the surface, and the protein was immobilized by covalent bond by the functional group on the surface. Next, measurement sensitivity was compared by an actual immunoassay (sandwich method) using Example and Comparative Example 3. In the examples, 200 μl of a 2% phosphate buffer solution of glutaraldehyde (manufactured by Wako, abt. 20% electron microscope) was previously added to each plate.
The mixture was dispensed at 1 / well, left at room temperature for 20 minutes, and then washed with pure water.
【0020】つづいて、実施例、比較例それぞれのプレ
ートの各ウェルに抗ヒトCRP抗体(タウンズ製)のリ
ン酸緩衝液(pH7.4)溶液(10μg/ml)を2
00μl/ウェルで分注し、37℃で2時間静置し吸着
させた。静置後ウェル内の溶液を捨て、0.05%Tw
een20を加えたリン酸緩衝液で3回洗浄した。洗浄
後、比較例については、各ウェルに3%BSA(インタ
ージェン社製 31473)リン酸緩衝液溶液(ブロッ
キング溶液)を200μl/ウェルで分注し室温で4時
間静置した。静置後ウェル内の溶液を捨て、0.05%
Tween20を加えたリン酸緩衝液で3回洗浄した。Subsequently, a phosphate buffer (pH 7.4) solution (10 μg / ml) of an anti-human CRP antibody (manufactured by Towns) was added to each well of each plate of the Examples and Comparative Examples.
The solution was dispensed at 00 μl / well and allowed to stand at 37 ° C. for 2 hours for adsorption. After standing, the solution in the well is discarded and 0.05% Tw
The plate was washed three times with a phosphate buffer containing een20. After washing, for a comparative example, 200 μl / well of a 3% BSA (International's 31473) phosphate buffer solution (blocking solution) was dispensed into each well and allowed to stand at room temperature for 4 hours. After standing, discard the solution in the well, and add 0.05%
The plate was washed three times with a phosphate buffer containing Tween 20.
【0021】次に各ウェルにCRP標準血清(タウンズ
製)のリン酸緩衝液溶液(0.001、0.01、0.
1、1、10、100μg/ml)を各濃度プレートの
2列(16ウェル)づつ100μl/ウェルで分注し、
室温で30分静置した。静置後ウェル内の溶液を捨て、
0.05%Tween20を加えたリン酸緩衝液で3回
洗浄した。洗浄後、各ウェルにPOD標識抗ヒトCRP
抗体(タウンズ製)のリン酸緩衝液溶液2.0μg/m
lを分注し室温で30分静置した。静置後ウェル内の溶
液を捨て、0.05%Tween20を加えたリン酸緩
衝液で3回洗浄した。洗浄後、POD発色キット(住友
ベークライト製 ML−1120T)を用いて発色、プ
レートリーダーで450nmの吸光度を測定した。結果
を表2に示す。Next, a CRP standard serum (Towns) phosphate buffer solution (0.001, 0.01, 0. 1) was added to each well.
1, 1, 10, 100 μg / ml) were dispensed at 100 μl / well in two rows (16 wells) of each concentration plate,
It was left at room temperature for 30 minutes. After standing, discard the solution in the well,
The plate was washed three times with a phosphate buffer containing 0.05% Tween20. After washing, each well contains POD-labeled anti-human CRP.
2.0 μg / m phosphate buffer solution of antibody (Towns)
1 was dispensed and allowed to stand at room temperature for 30 minutes. After standing, the solution in the well was discarded, and the well was washed three times with a phosphate buffer containing 0.05% Tween20. After washing, the color was developed using a POD color development kit (ML-1120T manufactured by Sumitomo Bakelite), and the absorbance at 450 nm was measured with a plate reader. Table 2 shows the results.
【0022】[0022]
【表2】 [Table 2]
【0023】比較例では低濃度領域において検体(CR
P標準血清)濃度に応じたシグナルの増加は認められな
いが、実施例では低濃度から高濃度全域において検体の
濃度に応じたシグナルの増加が認められた。また、比較
例では最も高い濃度においてシグナルの減少が確認さ
れ、これは検体の夾雑蛋白の吸着による標識抗体の反応
阻害によるものと考えられる。即ち、比較例に於いては
低濃度領域では標識抗体の非特異的吸着によるノイズ
(バックグラウンド)が高く、高濃度においては夾雑蛋
白の吸着による反応阻害により検体の濃度に応じたシグ
ナルが得られないのに対し、実施例では非特異的吸着が
排除されているために低濃度から高濃度領域まで、抗原
−抗体反応のみに依存した正確なシグナルが得られるこ
とが示された。In the comparative example, the specimen (CR
Although no increase in signal was observed in accordance with the concentration of (P standard serum), in Examples, an increase in signal in accordance with the concentration of the sample was observed in the entire range from low to high concentrations. In the comparative example, a decrease in the signal was confirmed at the highest concentration, which is considered to be due to the inhibition of the reaction of the labeled antibody due to the adsorption of the contaminating protein of the sample. That is, in the comparative example, the noise (background) due to the nonspecific adsorption of the labeled antibody is high in the low concentration region, and the signal corresponding to the concentration of the sample is obtained at the high concentration due to the reaction inhibition by the adsorption of the contaminating protein. In contrast, in the examples, non-specific adsorption was excluded, and it was shown that an accurate signal depending only on the antigen-antibody reaction was obtained from a low concentration to a high concentration region.
【0024】[0024]
【発明の効果】本発明の高感度免疫分析用容器は、表面
にグラフトされた親水性の高分子と官能基により、免疫
分析の測定系から非特異的吸着を排除し、固相化分子を
共有結合にて確実に固相化することで、ブロッキング操
作を省略し、低濃度から高濃度領域まで検体濃度に応じ
た高感度な測定が可能である。The container for high-sensitivity immunoassay of the present invention eliminates nonspecific adsorption from the immunoassay measurement system by using a hydrophilic polymer and a functional group grafted on the surface, and removes immobilized molecules. By solid-phase immobilization by covalent bonding, a blocking operation is omitted, and high-sensitivity measurement according to the analyte concentration can be performed from a low concentration to a high concentration region.
【図面の簡単な説明】[Brief description of the drawings]
【図1】末端に官能基、側鎖に親水性基をもつポリマー
鎖のグラフト。FIG. 1 is a graft of a polymer chain having a functional group at a terminal and a hydrophilic group at a side chain.
【図2】末端に親水性基、側鎖に官能基をもつポリマー
鎖のグラフト。FIG. 2 is a graft of a polymer chain having a hydrophilic group at a terminal and a functional group at a side chain.
【図3】末端に官能基をもつ親水性ポリマーのグラフ
ト。FIG. 3 shows a graft of a hydrophilic polymer having a terminal functional group.
【図4】側鎖に親水性基と官能基をもつポリマー鎖のグ
ラフト。FIG. 4 is a graft of a polymer chain having a hydrophilic group and a functional group in a side chain.
【図5】側鎖に親水性基と官能基をもつポリマー鎖のグ
ラフト。FIG. 5 is a graft of a polymer chain having a hydrophilic group and a functional group in a side chain.
【図6】親水性ポリマーと官能基のグラフト。FIG. 6 shows a graft of a hydrophilic polymer and a functional group.
1.官能基 2.親水性基又は親水性ポリマー、 3.ポリマー鎖 1. Functional group 2. 2. hydrophilic groups or hydrophilic polymers; Polymer chains
Claims (4)
材部分に官能基を有する親水性の高分子がグラフト化さ
れている事を特徴とする高感度免疫分析容器。1. A highly sensitive immunoassay container characterized in that a hydrophilic polymer having a functional group is grafted on at least a substrate portion of the container that comes into contact with a reagent solution.
材部分に官能基及び親水性の高分子がグラフト化されて
いる事を特徴とする高感度免疫分析容器。2. A highly sensitive immunoassay container characterized in that a functional group and a hydrophilic polymer are grafted on at least a substrate portion of the container that comes into contact with the reagent solution.
の水との接触角が1度以下である請求項1又は2記載の
高感度免疫分析容器。3. The high-sensitivity immunoassay container according to claim 1, wherein the contact angle with water of at least the substrate portion in contact with the reagent solution is 1 degree or less.
素の少なくとも一つと結合することができる請求項1又
は2記載の高感度免疫分析容器。4. The highly sensitive immunoassay container according to claim 1, wherein the functional group can bind to at least one of a peptide, protein, nucleic acid, and enzyme.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000085356A JP2001272406A (en) | 2000-03-24 | 2000-03-24 | Container for high-sensitivity analysis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000085356A JP2001272406A (en) | 2000-03-24 | 2000-03-24 | Container for high-sensitivity analysis |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001272406A true JP2001272406A (en) | 2001-10-05 |
Family
ID=18601710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000085356A Pending JP2001272406A (en) | 2000-03-24 | 2000-03-24 | Container for high-sensitivity analysis |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2001272406A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005527807A (en) * | 2002-04-12 | 2005-09-15 | ミクロナス ゲーエムベーハー | Method for immobilization of molecules on surfaces |
JP2007127630A (en) * | 2005-10-07 | 2007-05-24 | Canon Inc | Structure with bonding functional group on substrate for use in bonding acquisition molecule for acquiring target substance |
JP2007288133A (en) * | 2006-03-24 | 2007-11-01 | Jsr Corp | Magnetic particles, and manufacturing method thereof |
WO2008038774A1 (en) | 2006-09-28 | 2008-04-03 | Fujifilm Corporation | Instrument for biochemical use having surface under the inhibition of nonspecific adsorption |
US8703289B2 (en) | 2005-11-01 | 2014-04-22 | Jsr Corporation | Organic polymer particles and process for producing the same, magnetic particles for diagnostics, carboxyl group-containing particles and process for producing the same, and probe-bound particles and process for producing the same |
-
2000
- 2000-03-24 JP JP2000085356A patent/JP2001272406A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005527807A (en) * | 2002-04-12 | 2005-09-15 | ミクロナス ゲーエムベーハー | Method for immobilization of molecules on surfaces |
JP2007127630A (en) * | 2005-10-07 | 2007-05-24 | Canon Inc | Structure with bonding functional group on substrate for use in bonding acquisition molecule for acquiring target substance |
US8703289B2 (en) | 2005-11-01 | 2014-04-22 | Jsr Corporation | Organic polymer particles and process for producing the same, magnetic particles for diagnostics, carboxyl group-containing particles and process for producing the same, and probe-bound particles and process for producing the same |
JP2007288133A (en) * | 2006-03-24 | 2007-11-01 | Jsr Corp | Magnetic particles, and manufacturing method thereof |
US7713627B2 (en) | 2006-03-24 | 2010-05-11 | Jsr Corporation | Magnetic particles comprising an organic polymer layer and method for producing the same |
JP4716034B2 (en) * | 2006-03-24 | 2011-07-06 | Jsr株式会社 | Magnetic particles and method for producing the same |
WO2008038774A1 (en) | 2006-09-28 | 2008-04-03 | Fujifilm Corporation | Instrument for biochemical use having surface under the inhibition of nonspecific adsorption |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2235183C (en) | Device and apparatus for the simultaneous detection of multiple analytes | |
EP0874242A1 (en) | Device and apparatus for the simultaneous detection of multiple analytes | |
JP2001272406A (en) | Container for high-sensitivity analysis | |
JP4534817B2 (en) | Protein detection method and peptide detection method | |
JP3681983B2 (en) | Immunoassay container | |
CN1589404B (en) | Analytical method for measuring content of the first analyte of smaple | |
EP0228225A2 (en) | Immunoassay kit and method employing modified solid surface | |
WO1999060401A1 (en) | Immunoassay reagents and immunoassay method | |
US7052887B2 (en) | Method for immobilization of (an) affinity reagent(s) on a hydrophobic solid phase | |
EP0333801B1 (en) | Test strip for diagnosis by multi-immunoassay system | |
JP2000304749A (en) | Specific binding immunoanalytical container | |
JP2005099040A (en) | Vessel for immunoassay | |
CA2487483C (en) | Device for the presentation of peptides or proteins, method for the preparation and use thereof | |
JP3598333B2 (en) | Measuring reagent and measuring method using quartz oscillator | |
JPH11174057A (en) | Immunity measuring base material | |
JP4352849B2 (en) | Plastic surface treatment method, plastic substrate and plastic biochip | |
JPH08136496A (en) | Biosensor | |
JP2005030913A (en) | Biochip | |
CN116047059A (en) | Biochip, kit and method for detecting target object to be detected | |
JPH0833395B2 (en) | Method for producing molded article for solid-phase immunoassay | |
JP4353091B2 (en) | Protein and peptide detection method | |
JP2003057241A (en) | Support medium for biochamically active substance, and manufacturing method therefor | |
CN116223808A (en) | Biochip, kit and biochip detection method for identifying interference type | |
JP2005010004A (en) | Biochip | |
CN1261669A (en) | Albumen and gene detecting plate and its preparing method and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20041118 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041126 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050124 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050916 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051111 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051228 |
|
A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20060110 |
|
A912 | Removal of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20060310 |